Skip to main content
SpringerLink
Log in

Bambuterol: Effects of a new anti-asthmatic drug

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Twenty-seven asthmatic outpatients were randomly treated with bambuterol 30 mg administered once daily before going to bed and sustained release terbutaline 10 mg twice daily in a 14 day, double blind cross over study. On all the parameters of bronchodilator effects, namely peak expiratory flow rate (PEF), use of extra beta-agonist puffs, asthma symptom score, and patient preference for one of the treatments, no statistically or clinically significant difference between the two treatments was found. No significant difference between treatments was observed in the number or severity of side-effects. Bambuterol administered once daily appears to be an effective anti-asthmatic treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Eriksson NE, Haglind K, Ljungholm K (1982) A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma. Br J Dis Chest 79: 202–204

    Google Scholar 

  2. Gnosspelius Y, Persson G, Eklund G, Nyberg L (1984) Bambuterol — a new terbutaline prodrug with prolonged effect duration. Respiration 46 [Suppl 1]: 94

    Google Scholar 

  3. Hussar BA (1975) Patient noncompliance. J Am Pharmacol Assoc NS 15: 183–193 and 201

    Google Scholar 

  4. Laursen LC, Taudorf E, Gnosspelius Y, Gymose E, Weeke B (1985) Long-term oral therapy with terbutaline and theophylline alone and combined, in asthma. Eur J Respir Dis 66: 82–90

    Google Scholar 

  5. Olsson OAT, Svensson LÅ (1984) New lipophile terbutaline ester prodrugs with long effect duration. Pharm Res 1: 18–23

    Google Scholar 

  6. Svensson LÅ, Olsson OAT (1983) Bambuterol — a terbutaline carbamate prodrug with long duration is also a selective inhibitor of pseudo cholinesterase. 186th ACS, National Meeting, Washington DC, 1983, Books of abstracts, abstract no. 18.

  7. Taudorf E, Bundgaard A, Fagerstrom P-O, Weeke E, Weeke B (1981) Terbutaline depot tablets in asthma. Allergy 36: 495–500

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department, Rigshospitalet, University Hospital, Copenhagen, Denmark

    B. K. Pedersen, L. C. Laursen, P. Faurschou & B. Weeke

  2. Department of Clinical Research, AB Draco, Lund, Sweeden

    Y. Gnosspelius

Authors
  1. B. K. Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. C. Laursen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Gnosspelius
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Faurschou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Weeke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pedersen, B.K., Laursen, L.C., Gnosspelius, Y. et al. Bambuterol: Effects of a new anti-asthmatic drug. Eur J Clin Pharmacol 29, 425–427 (1985). https://doi.org/10.1007/BF00613456

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00613456

Key words

Search

Navigation